Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.74 USD | -0.18% | -3.90% | -15.65% |
10/05 | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
08/05 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |